Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland’s Personalized Health Program.
PRESS RELEASE
UNIVERSITY OF HELSINKI
10 million euros investment boosts Finnish capabilities in cancer immunotherapy
![](/wp-content/uploads/2020/05/cancer_immunotherapy.jpg)